Yttrium-90 selective internal radiation therapy on liver cancer: the past, the present, and the future
10.12025/j.issn.1008-6358.2025.20250142
- VernacularTitle:钇-90选择性内放射治疗肝癌的过去、现在与未来
- Author:
Jingqin MA
1
,
2
,
3
;
Linhong ZHANG
4
;
Minjie YANG
1
,
2
,
3
;
Jiabin CAI
5
;
Ying FANG
6
;
Rong LIU
1
,
2
,
3
;
Xudong QU
1
,
2
,
3
;
Lingxiao LIU
1
,
2
,
3
;
Zhiping YAN
1
,
2
,
3
Author Information
1. Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China
2. Shanghai Institution of Medical Imaging, Shanghai 200032, China
3. National Clinical Research Center for Interventional Medicine, Shanghai 200032, China.
4. Department of Interventional Radiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
5. Department of Liver Surgery and Transplantation, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
6. Department of Gastroenterology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
- Publication Type:Monographicreport:Yttrium-90microsphereinternalradiationtherapyonlivercancer
- Keywords:
Yttrium-90;
selective internal radiation therapy;
liver cancer
- From:
Chinese Journal of Clinical Medicine
2025;32(1):3-8
- CountryChina
- Language:Chinese
-
Abstract:
Yttrium-90 selective internal radiation therapy (90Y-SIRT) is a treatment technique that delivers radioactive microspheres precisely to the arterial vascular bed of neoplasms, utilizing beta radiation to administer a high local dose of radiation to the neoplasm tissues. This technology has demonstrated significant efficacy in patients with unresectable pirmary liver cancers and liver metastases. This article systematically reviews the development history and clinical application status of 90Y-SIRT in the treatment of liver cancer, and looks forward to future development directions.
